Trial Profile
A Phase II clinical trial of BI 425809 for Alzheimer's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2018
Price :
$35
*
At a glance
- Drugs Iclepertin (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 14 Feb 2018 New trial record